Coronavirus Breakthrough As Scientists Discover A Drug Used To Treat HEAD LICE Can Kill COVID-19 Cel

[LeeLemonoil]

Ivermectin effective in 83% hospitalized covid patients

Covid-19: WHO-sponsored preliminary review indicates Ivermectin effectiveness (2020)

WHO-sponsored review of ivermectin trials indicates 83% reduction in covid mortality.

swprs.org

Home

FLCCC is The Frontline COVID-19 Critical Care Alliance: Dedicated to COVID prevention & treatment, empowering individuals for better health.

covid19criticalcare.com

 

[AdoTintor]

Meta analysis (presentation) of all the the published studies on Invermectin.

 

[LeeLemonoil]

New:

https://b3d2650e-e929-4448-a527-4eeb59304c7f.filesusr.com/ugd/593c4f_8cb655bd21b1448ba6cf1f4c59f0d73d.pdf

Discussion

This review and meta-analysis confirms that ivermectin substantially reduces the risk of a person dying from COVID-19by probably somewhere in the region of65% to 92%.The only uncertainty in the evidence relatesto the precise extent of the reduction, not in the effectiveness of ivermectin itself. Similarly, when ivermectin is used as prophylaxisamong health care workers and contacts, it is clear that ivermectin substantially reduces COVID-19 infections, probably somewhere in the region of 88% (82% to 92%). Data from numerous currently active RCTswillhelp to determine the precise extent of its protective effect in these at risk groups.Despite the FLCCC’s strong recommendation that ivermectin should be implemented globally to save lives from COVID-19, most governments and health professionals still appear to be unaware of this profoundly effective COVID-19treatment.Not only is ivermectina safe, effectiveand well-knownmedicine,at an estimated cost of less than10 pence per person treated with a 12 mg tablet, it does indeed seem like a miracle drugin the context of the current global COVID-19 situation.26Guidance and protocols on using ivermectin for COVID-19 can be found on the FLCCC website https://covid19criticalcare.com.ConclusionsIvermectin is an essential drug to reduce morbidity and mortality from COVID-19 infection. Placebo-controlled trials of ivermectin treatmentamong people with COVID-19 infection are no longer ethicaland active placebo-controlled trials should be closed.

 

[LeeLemonoil]

https://b3d2650e-e929-4448-a527-4eeb5930...f4c59f0d73d.pdf

URGENTCOVID-19 information: Ivermectin reducesthe risk ofdeath from COVID-19 –a rapid review and meta-analysis in support oftherecommendationofthe Front Line COVID-19 Critical Care Alliance.

Backgroundto this rapid reviewRecently a group of expert critical care physicians, called the Front Line COVID-19 Critical Care Alliance (FLCCC), reviewed the evidence on the effectsof ivermectin on SARS-CoV-2 virus and COVID-19 infections.1Theyconcludedthat the evidence on ivermectin “demonstrates a strong signal of therapeutic efficacy” and recommendedthat ivermectin is adopted globally and systematically for the prophylaxis and treatment of COVID-19.1Ivermectinis an anti-parasitic medication widely usedin low-and middle-income countries to treatparasitic worm infectionsin adults and children.1,2Having been usedfor decades for this purpose, itis considered extremely safe and effective2,3and has an increasing list of indications due to its antiviraland anti-inflammatory properties.4Onthe WHO’s Model List of Essential Medicinesit is retainedin the form ofa 3 mg tablet.5Forparasitic infectionsin adults, ivermectin is commonly administeredas a single12 mg oral dose(0.2mg/kg).The FLCCC reviewsummarizesthe findings of27studiesevaluating ivermectin for prophylaxis and treatment of COVID-19 infection; however, it doesnot includemeta-analyses for the majority of outcomes. The FLCCChas called upon national and international
2health care agencies to devote the necessary resources to checking and confirming this groundbreaking evidence.Given the urgencyof the situation, Iundertook thisrapid systematic review and meta-analysisof studies included in the FLCCC paper to validate the FLCCC’s conclusions



This review and meta-analysis confirms that ivermectin substantially reduces the risk of a person dying from COVID-19by probably somewhere in the region of65% to 92%.The only uncertainty in the evidence relatesto the precise extent of the reduction, not in the effectiveness of ivermectin itself. Similarly, when ivermectin is used as prophylaxisamong health care workers and contacts, it is clear that ivermectin substantially reduces COVID-19 infections, probably somewhere in the region of 88% (82% to 92%). Data from numerous currently active RCTswillhelp to determine the precise extent of its protective effect in these at risk groups.Despite the FLCCC’s strong recommendation that ivermectin should be implemented globally to save lives from COVID-19, most governments and health professionals still appear to be unaware of this profoundly effective COVID-19treatment.Not only is ivermectina safe, effectiveand well-knownmedicine,at an estimated cost of less than10 pence per person treated with a 12 mg tablet, it does indeed seem like a miracle drugin the context of the current global COVID-19 situation.26Guidance and protocols on using ivermectin for COVID-19 can be found on the FLCCC website https://covid19criticalcare.com.Conclusi...1623;Ivermectin is an essential drug to reduce morbidity and mortality from COVID-19 infection. Placebo-controlled trials of ivermectin treatmentamong people with COVID-19 infection are no longer ethicaland active placebo-controlled trials should be closed

 

[LeeLemonoil]

This is big. Not only effective in severe cases but also mild to moderat. More effective than controls which were Loinavir/Ritonavir.

Ivermectin shows clinical benefits in mild to moderate Covid19 disease: A randomised controlled double blind dose response study in Lagos.
https://www.medrxiv.org/content/10.1101/...1.05.21249131v1

@haidut
@LLight
@Tristan Loscha

 

[Tristan Loscha]

This is big. Not only effective in severe cases but also mild to moderat. More effective than controls which were Loinavir/Ritonavir.

Ivermectin shows clinical benefits in mild to moderate Covid19 disease: A randomised controlled double blind dose response study in Lagos.
https://www.medrxiv.org/content/10.1101/...1.05.21249131v1

@haidut
@LLight
@Tristan Loscha

Very interesting. They used IV administration of the drug, do they also talk about other routes such as peroral? Ivermectin seems quite promising indeed.

 

[LLight]

Thanks.

Sadly these studies are still ignored in France and in other countries too I guess.

Our clinical trials were never finished while Macron was saying in march that "We are at war". Pathetic.

The corruption is patent but people are too brainwashed (and censorship is too important) for them to see it.

The "vaccine is the only exit" propaganda is everywhere while there is a significant chance that they won't change a thing.

 

[Braveheart]

again, for the most up to date info on Ivermectin....https://covid19criticalcare.com/

 

[LeeLemonoil]

YouTube is deleting videos from trained scientists and doctors just presenting the data about Ivermectin

 

[Prosper127]

This video won't last long on youtube...


View: https://youtu.be/oA-fTaGadyc

Ivermectin for COVID-19: real-time analysis of all 172 studies

Ivermectin for COVID-19: real-time analysis of all 172 studies

c19ivermectin.com